We describe a multiplex real-time PCR assay for use on the ABI 7500 Fast TaqMan platform to detect all currently described Klebsiella pneumoniae carbapenemases (KPC), New Delhi metallo-␤-lactamases (NDM), and the OXA-48-like family of carbapenemases from bacterial culture lysates or sample enrichment broth lysates.
T
he prevention of transmission of carbapenemase-producing organisms (CPO) within health care facilities requires accurate and rapid laboratory detection methods so that infection control precautions may be quickly implemented. In the midst of an outbreak, rapid case identification is required, and conventional methods can take too long and be very labor intensive, resulting in delays in infection control and significant costs to the health care system. Molecular methods are fast and generally have higher sensitivity and specificity than phenotypic methods, and methods developed in-house are typically less expensive than commercially available kits. The published methods for the molecular detection of Klebsiella pneumoniae carbapenemases (KPC), New Delhi metallo-␤-lactamases (NDM), and OXA-48 are typically singleplex reactions targeting only one carbapenemase or are intended for cultured isolates rather than surveillance samples (1) (2) (3) (4) (5) (6) (7) (8) (9) (10) (11) (12) (13) (14) . We identified the need for a highly sensitive and specific molecular assay that can detect these CPO gene targets directly from surveillance sample matrices, such as rectal swabs.
We developed a Fast multiplex real-time 5= exonuclease-based PCR assay to detect the common carbapenemases (KPC, NDM, and OXA-48-like) from rectal swabs in enrichment broths. Although there have been several reports of real-time PCR assays in the literature (1) (2) (3) (4) (5) (6) (7) (8) (9) (10) (11) (12) (13) (14) , to our knowledge, this is the first Fast multiplex real-time 5= exonuclease-based real-time PCR to detect and differentiate the 3 carbapenemases, KPC, NDM, and OXA-48-like, from rectal swabs in enrichment broths in a single reaction. A culture enrichment step was incorporated to increase the sensitivity (15 PCR controls, ATCC strains, and clinical isolates previously characterized by conventional PCR (16) are listed in Table 2 . Bacterial culture lysates were prepared using InstaGene Matrix (Bio-Rad, Mississauga, ON), according to the manufacturer's protocol. Broth lysates were prepared by 2 methods: InstaGene Matrix and a water boil. For each lysis method, approximately 30 l of enriched culture broth was added to 1 ml of PCR-grade water. InstaGene lysates were completed according to the manufacturer's protocol. The tube for the boil method was heated to 100°C in a dry bath for 8 min to lyse the bacterial cells. A 500-bp oligonucleotide containing 1 copy of the concatenated target sequences of each assay was purchased from IDT (Toronto, ON). Pooled negative InstaGene lysates were spiked with serial dilutions of this oligonucleotide ranging from 10 1 to 10 8 copies/ml. The limit of detection was assessed in both multiplex and simplex formats. All 3 targets have a lower detection limit of 5 copies/l extracted DNA.
A total of 155 blind-coded InstaGene lysates from archived clinical isolates previously tested by conventional PCR were tested by real-time PCR, and the results for each method were compared to determine the sensitivity and specificity. The multiplex assay correctly identified all 45 positive isolates as having at least 1 of the 3 carbapenemases tested ( Table 3) . The remaining 110 isolates tested were negative for KPC, NDM, and OXA-48 by both conventional PCR and real-time PCR assays. There was no evidence of cross-reactions among these three targets. The sensitivity and specificity are 100%.
A total of 268 surveillance rectal swabs collected by the participating hospital, as part of their infection control surveillance program, were used. The swabs were enriched in 5 ml of Tris-buffered saline (TSB) with a 10-g ertapenem disc for 18 to 24 h of incubation at 37°C, in a stationary position, in an ambient air incubator and then lysed and tested with the multiplex real-time PCR. The results were compared to those for isolates recovered from the same broth (Table 4 ) and investigated as follows. Isolates recovered from broths were obtained by subculturing the broths to 2 MacConkey agar plates (Oxoid) with imipenem and meropenem discs (Bio-Rad, Mississauga, ON). Colonies growing within the zone of inhibition were identified to the species level, and antibiotic susceptibility testing was performed according to the 2014 CLSI guidelines. Isolates intermediate or resistant to imipenem or meropenem were submitted to the reference laboratory for conventional PCR testing. As there is no gold standard for the detection of carbapenemases directly from stool or rectal swab samples (17) , we considered our current phenotypic screening followed by the conventional PCR method as the reference method for comparison.
One hundred percent of conventionally identified KPC/ NDM/OXA-48-positive screen isolates were identified by the real-time PCR assay. None of the screen isolates harbored VIM or IMP genes. Three enrichment broths had discordant results between phenotypic testing and real-time PCR. Enrichment broths 102 and 220 both tested as phenotypically ertapenem and meropenem susceptible, but both tested positive for the presence of NDM by real-time PCR. Broth 220 had a second enrichment broth tested, which had an NDM-positive K. pneumoniae isolate recovered. Broth 102 had no carbapenem-resistant organisms isolated, and repeat testing could not be performed. Broth 239 tested as NDM positive and OXA-48 positive by realtime PCR, but only an NDM-positive Escherichia coli was isolated initially. A second screen sample 1 week later from the same patient recovered an OXA-48-positive K. pneumoniae isolate.
This real-time PCR assay is fast and simple to perform, and the results are easier to interpret than those for the conventional PCR. Replacing the current method of conventional PCR with the realtime PCR will significantly reduce turnaround times for CPO detection, especially during an outbreak. For clinical laboratories, a real-time PCR application will reduce the turnaround time for implementing infection control measures and reduce the costs associated with CPO detection. 
